Compliances Certificate under Reg. 74(5).
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transgene Biotek has submitted a quarterly compliance certificate to BSE as required under SEBI Regulation 74(5). The certificate, issued by the company's Registrar and Share Transfer Agent Bigshare Services Private Limited, covers the period from January 1, 2025 to March 31, 2025. It confirms that all shares received from depository participants for dematerialization during the quarter were properly processed, confirmed to NSDL and CDSL, and that the share certificates were cancelled and the depository names substituted in the register of members within the required 15-day window. The filing is signed by Dr. K. Koteswara Rao, Chairman & Managing Director, and dated April 19, 2025.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms that the company's share dematerialization processes are functioning normally.